Leveraging laboratory and clinical studies to design effective antibiotic combination therapy
- 8 October 2021
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 64, 68-75
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolutionCurrent Opinion in Microbiology, 2015
- Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewJournal of Research in Pharmacy Practice, 2015
- Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Mechanism-independent method for predicting response to multidrug combinations in bacteriaProceedings of the National Academy of Sciences, 2012
- Combination Therapy for Treatment of Infections with Gram-Negative BacteriaClinical Microbiology Reviews, 2012
- Correction: Optimal Drug Synergy in Antimicrobial TreatmentsPLOS Computational Biology, 2010
- Optimal Drug Synergy in Antimicrobial TreatmentsPLOS Computational Biology, 2010
- Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1995
- Treatment of Disease Due to Mycobacterium intracellulareClinical Infectious Diseases, 1981
- Treatment of Pulmonary Tuberculosis with Streptomycin and Para-Amino-Salicylic AcidBMJ, 1950